A. Bailey

发表

Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat.

Peter D Smith, A. Rabow, R. A. Norman, 2016, ACS medicinal chemistry letters.

Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators.

R. A. Norman, James S. Scott, A. Bailey, 2015, Journal of medicinal chemistry.

From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.

G. Pairaudeau, A. Bailey, E. Cadogan, 2012, Bioorganic & medicinal chemistry letters.

Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonists.

G. Pairaudeau, A. Bailey, E. Cadogan, 2011, Bioorganic & medicinal chemistry letters.

Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.

G. Pairaudeau, A. Bailey, E. Cadogan, 2011, Bioorganic & medicinal chemistry letters.

Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.

A. Bailey, David Cox, P. Leff, 1999, Journal of medicinal chemistry.

Synthesis of trans 8-substituted-6-phenyl-6,7,8,9-tetrahydro-3H-pyrazolo [4,3-f]isoquinolines using a Pictet-Spengler approach

James S. Scott, A. Bailey, T. Moss, 2018, Tetrahedron Letters.

From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

P. Leeson, B. Springthorpe, P. Barton, 2007, Bioorganic & medicinal chemistry letters.

Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.

G. Pairaudeau, A. Bailey, E. Cadogan, 2014, ACS medicinal chemistry letters.

The discovery of AZD 3199 A new inhaled ultra-long acting 2 receptor agonist with rapid onset of action

David, A. Bailey, E. Cadogan, 2014 .

The discovery of new spirocyclic muscarinic M3 antagonists.

Daniel J. Warner, G. Pairaudeau, A. Bailey, 2010, Bioorganic & medicinal chemistry letters.

Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy.

A. Bailey, Robert D. M. Davies, Alastair J. H. Brown, 2017, Journal of medicinal chemistry.

The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.

B. Huck, A. Bailey, S. Rundlett, 2005, Bioorganic & medicinal chemistry letters.

The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors.

B. Huck, A. Bailey, S. Rundlett, 2004, Bioorganic & Medicinal Chemistry Letters.

Facile synthesis of 4-aryl and alkyl substituted, N6-alkylated pyridazine-3,6-diamines

A. Bailey, Joanna Wlochal, 2015 .

Discovery of a Thiadiazole-Pyridazine Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.

Mairi M. Littleson, Peter D Smith, Peng-Fei Wang, 2019, Journal of medicinal chemistry.

Synthesis of 8-substituted-6-phenyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolines using Pictet-Spengler and Bischler-Napieralski cyclisation methods

James S. Scott, A. Bailey, Robert D. M. Davies, 2018, Tetrahedron Letters.

Preparation of differentially substituted 3,6-diaminopyridazines under mild conditions

A. Bailey, Bryan E. Roberts, Paul A. Bethel, 2014 .

Experimental testing of quantum mechanical predictions of mutagenicity: aminopyrazoles.

A. Bailey, A. Leach, C. Mee, 2013, Chemical research in toxicology.

Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader Antagonists.

Paul R. J. Davey, James S. Scott, A. Bailey, 2019, Journal of medicinal chemistry.